SCM
AGL icon

Sirios Capital Management’s Agilon Health AGL Stock Holding History

Sirios Capital Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,158
Closed -$363K – 62
2023
Q4 		$363K Sell
1,158
-1,241
-52% -$449K 0.07% 52
2023
Q3 		$1.07M Sell
2,399
-169
-7% -$76.3K 0.2% 46
2023
Q2 		$1.11M Buy
2,568
+969
+61% +$545K 0.19% 50
2023
Q1 		$949K Sell
1,599
-12
-0.7% -$6.72K 0.17% 57
2022
Q4 		$650K Sell
1,611
-1,117
-41% -$524K 0.12% 51
2022
Q3 		$1.6M Sell
2,728
-49
-2% -$29.3K 0.3% 48
2022
Q2 		$1.52M Sell
2,777
-105
-4% -$53.1K 0.27% 46
2022
Q1 		$1.83M Sell
2,882
-1,580
-35% -$814K 0.24% 48
2021
Q4 		$3.01M Buy
+4,462
New +$2.72M 0.34% 53

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sirios Capital Management's AGL Position: Q1 2024 in Review

Sirios Capital Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 1,158 shares — an estimated $363K sold.

Sirios Capital Management first reported a position in AGL in Q4 2021 and held it in 9 quarters. The position peaked at $3.01M in Q4 2021. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • Sirios Capital Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • Sirios Capital Management sold 1,158 Agilon Health shares in Q1 2024, an estimated $363K.
  • Sirios Capital Management first reported a position in Agilon Health in Q4 2021 and held it in 9 quarters.
  • Sirios Capital Management's Agilon Health position peaked at $3.01M in Q4 2021.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Sirios Capital Management's 13F filing for Q1 2024, filed 15 May 2024.